In this study, we evaluated the potential role of SNPs in STAT4, PTPN2, PSORS1C1, and TRAF3IP2 genes on the response to ETN and ADA treatment in RA patients. The gene discussed is TRAF3IP2; the disease is rheumatoid arthritis.